This collaboration strengthens Lindus’ ability to deliver robust end-to-end clinical trials through one unified solution.
October 16, 2025
2
mins read
Lindus Health Partners with Yendou to Streamline Site Engagement and Accelerate Clinical Trial Feasibility
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms
8/22/24
3
mins
Sharing recent developments from our recent trials with Woebot Health.
Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials
8/6/24
Introducing our "All-in-One Dermatology CRO" bespoke to dermatology clinical trials.
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
7/24/24
4
Announcing our Phase 2a clinical trial with PILA PHARMA to assess the tolerability, safety, and efficacy of XEN-D0501 in patients with type II diabetes and obesity.
Lindus Health and Aktiia to launch observational clinical trial for Aktiia’s Optical Blood Pressure Monitoring Device
7/9/24
We're pleased to announce the launch of our 7,500-participant trial with Aktiia!
CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
4/11/24
Announcing our recent collaboration with CLEO Diagnostics for an ovarian cancer detection clinical trial.
Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials
6/27/24
Introducing our newest CRO, site services, and eClinical technology offering to the medical device market.
